| The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) |
Placebo, Sulindac 400 MG |
Active, not recruiting |
| Implementation and Effectiveness Trial of HN-STAR |
HN-STAR Intervention |
Active, not recruiting |
| Comparing Two Methods to Follow Patients With Pancreatic Cysts |
Computed Tomography, Endoscopic Ultrasound, Magnetic Resonance Imaging, Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
| Marker Driven Selection of Patients for Prostate Biopsy and Management |
|
Active, not recruiting |
| Cohort Study of Pancreatic Cancer Risk |
|
Active, not recruiting |
| A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer |
Bilateral Salpingectomy, Bilateral Salpingectomy with Oophorectomy, Biospecimen Collection, Quality-of-Life Assessment, Questionnaire Administration, Transvaginal Ultrasound, Ultrasound Imaging |
Recruiting |
| Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV |
9 valent human papillomavirus vaccine (Types 6, 11, 16, 18, 31, 33, 45, 52, 58), Saline Placebo |
Active, not recruiting |
| Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents Living With HIV, OPTIMO Trial |
Recombinant Human Papillomavirus Nonavalent Vaccine |
Active, not recruiting |
| Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas |
Blood Sample collection, Data collection, Tissue sample collection |
Recruiting |
| Clinical Trial of Green Tea Catechins in Men on Active Surveillance |
Placebo, Sunphenon |
Active, not recruiting |
